Your browser doesn't support javascript.
loading
The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy.
Rao, Shalini S; Portbury, Stuart D; Lago, Larissa; Bush, Ashley I; Adlard, Paul A.
Affiliation
  • Rao SS; Melbourne Dementia Research Centre, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Portbury SD; Melbourne Dementia Research Centre, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Lago L; Melbourne Dementia Research Centre, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Bush AI; Melbourne Dementia Research Centre, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Adlard PA; Melbourne Dementia Research Centre, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
J Alzheimers Dis ; 77(2): 753-771, 2020.
Article in En | MEDLINE | ID: mdl-32741833
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenotype / Iron Chelating Agents / Tauopathies / Disease Models, Animal / Deferiprone Limits: Animals Language: En Journal: J Alzheimers Dis Journal subject: GERIATRIA / NEUROLOGIA Year: 2020 Document type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenotype / Iron Chelating Agents / Tauopathies / Disease Models, Animal / Deferiprone Limits: Animals Language: En Journal: J Alzheimers Dis Journal subject: GERIATRIA / NEUROLOGIA Year: 2020 Document type: Article Affiliation country: Australia